Basal-like cancers are characteristically negative for ER, PR and HER2 expression (i.e. triple negative) but may express basal cytokeratins (CK5-6 and CK14) and the epidermal growth factor receptor (EGFR) (Nielsen et al, 2004; Rakha et al, 2006). This evidence concerns the gene EGFR and cancer.